162 related articles for article (PubMed ID: 2389423)
1. 15-Deoxyspergualin after cardiac and renal allotransplantation in primates.
Reichenspurner H; Hildebrandt A; Human PA; Boehm DH; Rose AG; Schorlemmer HU; Reichart B
Transplant Proc; 1990 Aug; 22(4):1618-9. PubMed ID: 2389423
[No Abstract] [Full Text] [Related]
2. 15-Deoxyspergualin for induction of graft nonreactivity after cardiac and renal allotransplantation in primates.
Reichenspurner H; Hildebrandt A; Human PA; Boehm DH; Rose AG; Odell JA; Reichart B; Schorlemmer HU
Transplantation; 1990 Aug; 50(2):181-5. PubMed ID: 2382284
[TBL] [Abstract][Full Text] [Related]
3. Effect of a novel immunosuppressive agent, deoxyspergualin, on rejection in kidney transplant recipients.
Takahashi K; Ota K; Tanabe K; Oba S; Teraoka S; Toma H; Agishi T; Kawaguchi H; Ito K
Transplant Proc; 1990 Aug; 22(4):1606-12. PubMed ID: 2389420
[No Abstract] [Full Text] [Related]
4. Synergistic effect of 15-deoxyspergualin and cyclosporine in prolonging survival of rat cardiac allografts.
Kaji H; Chou DT; Sutherland DE; Stephanian E; Gores PF
Transplant Proc; 1994 Apr; 26(2):869-70. PubMed ID: 8171689
[No Abstract] [Full Text] [Related]
5. Immunosuppressive effect of deoxyspergualin on acute renal allograft rejection in dogs.
Fukao K; Otsuka M; Iwasaki H; Yuzawa K; Iwasaki Y
Transplant Proc; 1989 Feb; 21(1 Pt 1):1090-3. PubMed ID: 2650068
[No Abstract] [Full Text] [Related]
6. Effect of 15-deoxyspergualin on experimental organ transplantation.
Todo S; Murase N; Kahn D; Pan CE; Okuda K; Cemej S; Casavilla A; Mazzaferro V; Ghalab A; Rhoe BS
Transplant Proc; 1988 Feb; 20(1 Suppl 1):233-6. PubMed ID: 3279614
[TBL] [Abstract][Full Text] [Related]
7. Remarkable recovery from rejection by treatment with deoxyspergualin and methylprednisolone on canine kidney allografts.
Suzuki S; Hayashi R; Niiya S; Kenmochi T; Fukuoka T; Amemiya H
Transplant Proc; 1991 Feb; 23(1 Pt 1):545-6. PubMed ID: 1990606
[No Abstract] [Full Text] [Related]
8. Synergistic effect of cyclosporine and mizoribine on graft survival in canine organ transplantation.
Hayashi R; Suzuki S; Shimatani K; Watanabe H; Kenmochi T; Fukuoka T; Niiya S; Amemiya H
Transplant Proc; 1990 Aug; 22(4):1676-8. PubMed ID: 2389432
[No Abstract] [Full Text] [Related]
9. Effective use of 15-deoxyspergualin in kidney transplantation.
Koyama I; Kadokura M; Hoshino T; Omoto R
Transplant Proc; 1989 Feb; 21(1 Pt 1):1088-9. PubMed ID: 2650067
[No Abstract] [Full Text] [Related]
10. Immunosuppressive mechanisms of 15-deoxyspergualin on heterotopic heart transplantation in rats.
Nakata S; Ito T; Shirakura R; Matsuda H; Fukuzawa M; Nakano S; Fukushima N; Kawashima Y
Transplant Proc; 1991 Feb; 23(1 Pt 1):864-5. PubMed ID: 1825004
[No Abstract] [Full Text] [Related]
11. Deoxyspergualin: clinical experience.
Gores PF
Transplant Proc; 1996 Apr; 28(2):871-2. PubMed ID: 8623441
[No Abstract] [Full Text] [Related]
12. Clinical application of 15-deoxyspergualin for treatment of acute graft rejection following renal transplantation.
Suzuki S; Hayashi R; Kenmochi T; Shimatani K; Fukuoka T; Amemiya H
Transplant Proc; 1990 Aug; 22(4):1615-7. PubMed ID: 2389422
[No Abstract] [Full Text] [Related]
13. 15-Deoxyspergualin is a more potent and effective immunosuppressant than cyclosporine but does not effectively suppress lymphoproliferation in vivo.
Yuh DD; Morris RE
Transplant Proc; 1991 Feb; 23(1 Pt 1):535-9. PubMed ID: 1990605
[No Abstract] [Full Text] [Related]
14. 15-Deoxyspergualin potentiates the immunosuppressive effect of cyclosporine A in a rat heart allograft model.
Gannedahl G; Wanders A; Carlsson M; Tufveson G
Transplant Proc; 1993 Feb; 25(1 Pt 1):768-9. PubMed ID: 8438473
[No Abstract] [Full Text] [Related]
15. Effectiveness of 15-deoxyspergualin on renal graft rejection.
Kozaki K; Matsuno N; Sakurai E; Tamaki I; Furuhashi K; Saito A; Yoshida M; Miyamoto K; Kozaki M
Transplant Proc; 1994 Aug; 26(4):1903-4. PubMed ID: 8066619
[No Abstract] [Full Text] [Related]
16. Mode of action of immunosuppressive drugs evaluated with the aid of the immunostimulator LS-2616: studies on rejecting rat cardiac allografts.
Wanders A; Gannedahl G; Gerdin B; Tufveson G
Transplant Proc; 1992 Feb; 24(1):274-5. PubMed ID: 1539280
[No Abstract] [Full Text] [Related]
17. Comparative studies on the immunosuppressive activity of FK506, 15-deoxyspergualin, and cyclosporine.
Ochiai T; Nakajima K; Sakamoto K; Nagata M; Gunji Y; Asano T; Isono K; Sakamaki T; Hamaguchi K
Transplant Proc; 1989 Feb; 21(1 Pt 1):829-32. PubMed ID: 2468228
[No Abstract] [Full Text] [Related]
18. The effect of 15-deoxyspergualin on hamster-to-rat cardiac xenograft survival.
Pruitt SK; Halperin EC; Bollinger RR
Transplant Proc; 1991 Feb; 23(1 Pt 1):585-6. PubMed ID: 1990618
[No Abstract] [Full Text] [Related]
19. Bromocriptine plus suboptimal cyclosporine treatment abrogates acute rejection of rat cardiac allografts.
Di Stefano R; Carmellini M; Carobbi A; Vaglini F; Petrini M; Ricci F; Mosca F; Malvaldi G
Transplant Proc; 1990 Aug; 22(4):2015-6. PubMed ID: 2389514
[No Abstract] [Full Text] [Related]
20. Effects of cyclosporine and 15-deoxyspergualin on coronary arteriosclerosis after heart transplantation in the rat.
Nagamine S; Ohmi M; Tabayashi K; Iguchi A; Mohri H
J Heart Lung Transplant; 1994; 13(5):895-8. PubMed ID: 7803433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
